Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Exenatide Injection

Approval Number

国药准字HJ20140821

CompanyASTRAZENECA AB

Registration Date

June 14, 2023

Previous Approval Numbers

H20140821

Drug Information

Generic Name

艾塞那肽注射液

Trade Name

百泌达

Dosage Form

注射剂

Strength

5μg（0.25mg/ml,1.2ml/支）

Drug Type

化学药品

Registration Date

June 14, 2023

Expiry Date

June 13, 2028

Company Information

Applicant Company

Company NameASTRAZENECA AB

Company Address

SE-151 85 Södertälje, Sweden

Manufacturing Company

Company NameBAXTER PHARMACEUTICAL SOLUTIONS LLC

Company Address

927 South Curry Pike, Bloomington, Indiana 47403, USA

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy